Bioidentical Hormone Replacement Therapy in Charleston & Mt. Pleasant SC

Reviewed by Ashley Harwyn, PA-C | A4M Board Certified | Updated September 4, 2026

Almost every page about bioidentical hormones argues about the word. This one starts with the two facts that actually decide your answer: how long ago your periods stopped, and whether the product you are offered is FDA approved.

The short version. The 2022 position statement of The North American Menopause Society says hormone therapy remains the most effective treatment for hot flashes, night sweats and the genitourinary syndrome of menopause, and prevents bone loss and fracture[1]. For women under 60 or within 10 years of menopause onset with no contraindications, it calls the benefit-risk ratio favorable[1]. Separately, bioidentical describes the molecule, not the approval: FDA-approved versions exist, and many products marketed under that word are compounded and not FDA approved[2].

Does hormone therapy actually work?

Yes, for what it is indicated for, and the specialty society says so without hedging. The 2022 statement is direct: hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause, and it has been shown to prevent bone loss and fracture[1].

Vasomotor symptoms is the clinical term for hot flashes and night sweats. The genitourinary syndrome of menopause covers vaginal dryness, pain with sex and the urinary changes that arrive with it. Those are the indications with the strongest evidence, and they are what an honest conversation should be organized around. See gynecology and fertility.

The same statement is equally clear that risk is not one number. It varies by type, dose, duration of use, route of administration, timing of initiation, and whether a progestogen is used, and it says treatment should be individualized to maximize benefit and minimize risk with periodic reevaluation[1].

The timing window, which decides more than the brand does

How long ago your periods stopped matters more than which brand you are offered.

This is the part most pages leave out. For women aged younger than 60, or who are within 10 years of menopause onset and have no contraindications, the guideline states the benefit-risk ratio is favorable for treatment of bothersome vasomotor symptoms and prevention of bone loss[1].

For women who begin hormone therapy more than 10 years from menopause onset, or who are older than 60, it says the benefit-risk ratio appears less favorable, because of the greater absolute risks of coronary heart disease, stroke, venous thromboembolism and dementia in that group[1].

Two women can be offered the identical prescription by the identical clinic and be in genuinely different situations, because one is three years past her final period and the other is fifteen. If nobody has asked you that question, the assessment has not started.

What does bioidentical actually mean?

Solcara Health on hormone changes through perimenopause and menopause.

It means the hormone molecule is structurally identical to the one your body produces. That is a chemistry statement, and it is often true. What it does not tell you is anything about how the product was made, tested or approved, which is where the whole argument actually lives.

The FDA has approved drugs containing hormones that are identical to the hormones made naturally by women in their reproductive years[2]. So an FDA-approved bioidentical hormone is a real category, not a contradiction, and for many women it is exactly what is appropriate.

The FDA also states that many marketed products called bioidentical hormones are compounded drugs, which are not FDA approved[2]. Both sentences are true of things sold under the same word. That is why the word by itself cannot answer any question you have.

What the FDA says about the compounded versions

Directly, and it is worth reading slowly. The agency states that it does not have evidence that compounded bioidentical hormones are safe and effective, or safer or more effective than FDA-approved hormone therapy[2]. That is not a claim that they are dangerous. It is a statement that the evidence to prefer them does not exist.

The National Academies review the FDA commissioned reached the same place from the research side. It found a lack of rigorous evidence of safety and effectiveness from well-designed or properly controlled clinical studies, and noted that the information came mostly from low quality data such as anecdotal claims, patient reports and prescriber testimonies[3].

On one specific ingredient the FDA is more pointed still: there are no FDA-approved drugs containing estriol, and it says it does not have evidence that drugs containing estriol are safe and effective or are safer forms of estrogen[2]. If a formulation you are offered contains estriol, that is a fact worth having in advance.

Interactive · 60 seconds

Where Do You Actually Sit?

Select what you have been experiencing. This is an educational reflection tool that points toward what is worth evaluating, not a diagnosis. Nothing is stored or sent anywhere.

Tap all that apply

Educational only. Not a diagnosis or a substitute for clinical evaluation.

What the guideline supports, and what it does not

What the guideline supports

Hormone therapy as the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause, with demonstrated prevention of bone loss and fracture, and a favorable benefit-risk ratio for women under 60 or within 10 years of menopause onset who have no contraindications. Treatment individualized, with periodic reevaluation.

What the evidence does not support

That compounded preparations are safer or better. The FDA says it has no evidence that compounded bioidentical hormones are safe and effective, or safer or more effective than FDA-approved hormone therapy, and the NASEM review it commissioned found the evidence base came mostly from anecdotal claims and prescriber testimonies. There are also no FDA-approved drugs containing estriol.

There is a version of this conversation where a clinic tells you the compounded custom blend is the natural, safer, superior option, and there is a version where somebody shows you the guideline and the FDA statement and lets you decide. The second one takes longer and it is the one that survives a second opinion.

If the main problem is dryness or pain, read this first

Systemic hormone therapy is not the only route, and for many women it is not the right one. For bothersome genitourinary symptoms not relieved with over-the-counter therapies, in women without an indication for systemic hormone therapy, the guideline recommends low-dose vaginal estrogen therapy or other options such as vaginal dehydroepiandrosterone or oral ospemifene[1].

That matters because it is a smaller intervention with a different risk profile, aimed precisely at the tissue involved. Being offered a systemic prescription for a local problem is one of the more common overshoots in this field. See vaginal health treatments and urinary incontinence options.

How this is assessed in Mount Pleasant and Charleston

The history first, and the first questions are the ones the guideline turns on: when your final period was, what the symptoms actually are and how much they cost you, and your personal and family history of clot, stroke, heart disease and breast cancer. Then testing chosen from that, then a plan with a review date attached to it.

Ashley Harwyn, PA-C sees patients in Mount Pleasant on Bramson Court and in downtown Charleston at the Longevity Club on Rutledge Avenue. If you are already on hormone therapy, bring the product name, the dose, the route and how long you have been on it, because the guideline's own framing is that all four change the risk calculation[1].

If the symptoms might not be hormonal at all

Several look identical from the outside and are separately treatable. See thyroid management, what persistent fatigue usually turns out to be and full panel lab testing.

If the genitourinary symptoms are the main problem

Often answerable without systemic therapy. See vaginal health treatments, the O-Shot and what the 2026 trial found and gynecology and fertility.

If you want the measurements and the wider picture

Hormones sit inside cardiovascular and metabolic risk rather than beside it. See advanced diagnostic testing, cardiac health and functional and preventive medicine.

What we will not do

We will not tell you a compounded preparation is safer than an approved one, because the FDA says the evidence for that does not exist[2]. We will not start systemic therapy for a local symptom that has a local answer, and we will not write a prescription with no review date, because periodic reevaluation is part of the recommendation rather than an optional extra[1].

To book a consultation, call 843-981-0870 or request an appointment through the form on this site. Bring the date of your final period if you know it, any hormone products you are currently using including creams and pellets, and any previous hormone panels. The date matters more than most people expect.

Questions women actually ask

Ashley Harwyn, PA-C A4M Board Certified · Founder, Solcara Health Online

Tap a question to ask

Does hormone therapy actually work? For the symptoms it is indicated for, yes, and the guideline is unambiguous. The 2022 position statement of The North American Menopause Society says hormone therapy remains the most effective treatment for vasomotor symptoms and for the genitourinary syndrome of menopause, and that it has been shown to prevent bone loss and fracture. That is a strong statement from the specialty society for this condition.

Is it safe? It depends heavily on when you start. The guideline states that for women younger than 60 or within 10 years of menopause onset, with no contraindications, the benefit-risk ratio is favorable for bothersome vasomotor symptoms and prevention of bone loss. For women starting more than 10 years out or over 60, it says the ratio appears less favorable because of greater absolute risks of coronary heart disease, stroke, venous thromboembolism and dementia.

What does bioidentical actually mean? It means the hormone molecule is structurally identical to the one your body makes. What it does not tell you is whether the product is FDA approved. The FDA has approved drugs containing hormones identical to the ones women make naturally, and separately notes that many products marketed as bioidentical hormones are compounded drugs, which are not FDA approved.

So is compounded the same thing? No. The FDA states it does not have evidence that compounded bioidentical hormones are safe and effective, or safer or more effective than FDA-approved hormone therapy. The NASEM review it commissioned found a lack of rigorous evidence from well-designed or properly controlled studies, and said the information came mostly from low quality data such as anecdotal claims and prescriber testimonies.

What about estriol, which some clinics use? There are no FDA-approved drugs containing estriol, and the FDA says it does not have evidence that drugs containing estriol are safe and effective or are safer forms of estrogen. If a formulation you are offered contains estriol, that is worth knowing before you start rather than after.

What should I ask before starting? Ask whether what you are being prescribed is an FDA-approved product or a compounded preparation, and which pharmacy makes it. Ask how far you are from your final period, because that single fact moves the risk calculation more than almost anything else. Then ask what the plan is for reevaluating it, since the guideline calls for periodic reassessment rather than an indefinite prescription.

What if my main problem is vaginal dryness or pain? Then you may not need systemic hormone therapy at all. For bothersome genitourinary symptoms not relieved by over-the-counter options, in women without an indication for systemic therapy, the guideline recommends low-dose vaginal estrogen or alternatives such as vaginal DHEA or oral ospemifene. That is a smaller intervention with a different risk profile.

How long can I stay on it? The guideline's answer is that longer durations should be for documented indications, such as persistent vasomotor symptoms, with shared decision-making and periodic reevaluation. There is no fixed stopping date, and there is also no version of this where nobody revisits the decision.

About the author

Ashley Harwyn, PA-C

Founder, Solcara Health · Board Certified in Anti-Aging and Functional Medicine (A4M)

Ashley has practiced medicine for more than fifteen years. Her path into it began at home, with a family member born with a congenital heart defect and a childhood spent watching how much the quality of a clinician's attention could change the shape of a life. She has since practiced across a range of settings, including medical mission work in Uganda, before founding Solcara to build the kind of practice she kept wishing existed, one that treats women as whole people and tells them the truth about what the evidence does and does not support.

Full bio →

References

U.S. Food and Drug Administration, HHS, and The Menopause Society sources.

The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028. Read the study on PubMed
US Food and Drug Administration. Menopause. Women's Health Topics, last updated December 14, 2023. Read the FDA statement
US Food and Drug Administration. National Academies of Science, Engineering, and Medicine (NASEM) Study on the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Therapy. Read the FDA statement

Be taken seriously, and told the truth

Book an evaluation at The Longevity Club, 163 Rutledge Avenue downtown, or our Mount Pleasant office.

BOOK A CONSULTATION →

Or call 843-981-0870

Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. It describes a regulatory labeling change and general treatment categories; it is not a recommendation that any individual start, stop, or change a medication. Hormone therapy of any kind, including local vaginal estrogen, requires evaluation by a qualified, licensed clinician who knows your personal and family history. Consult a qualified healthcare provider before making medical decisions. Information reflects sources available as of August 20, 2026.

Ashley Harwyn, PA-C, is Board Certified in Anti-Aging and Functional Medicine (A4M) and the founder of Solcara Health. Solcara serves South Carolina from Downtown Charleston (163 Rutledge Ave, Ste 202, The Longevity Club) and Mt. Pleasant (496 Bramson Ct, Ste 120).

visit our ZO store

Shop ALASTIN Skincare^®

Bioidentical Hormone Replacement Therapy FAQ's

Quick Links

Solcara Health | Mt. Pleasant

Solcara Health in Longevity Club

Bioidentical Hormone Replacement Therapy in Charleston and Mt. Pleasant, SC

Does hormone therapy actually work?

The timing window, which decides more than the brand does

What does bioidentical actually mean?